Is Minimal Residual Disease Monitoring Clinically Relevant in Adults with Acute Myelogenous Leukemia

摘要: In the past year, there has been increasing attention towards understanding clinical relevance of minimal residual disease (MRD) assessment. The monitoring MRD levels at various stages therapy considerable potential to impact guidance treatment for AML patients and improve outcomes. Thus, efforts have increased address important concerns regarding measurements. These include: (1) what should be monitored; (2) methodologies used; (3) whether such are standardized across laboratories; (4) how prognostic defined; (5) when (6) options available positive patients. this review, we will discuss studies date aiming around use measurements